$heff's $tation of $tocks & $olid DD

[Investor100]

AVII:AVI BioPharma Announces FDA Approval to Proceed With a Modified Dosing of AVI-6003 for Treatment of Marburg Virus

AVI-7288, a Component of AVI-6003, Shows Efficacy Results in Standalone Treatment of Non-Human Primate Studies


BOTHELL, WA--(Marketwire -02/28/12)- AVI BioPharma, Inc. (NASDAQ: AVII - News), a developer of RNA-based therapeutics, today announced that it has received approval from the Food and Drug Administration (FDA) to proceed with a single oligomer, AVI-7288, in studies in both humans and non-human primates to support the safety and efficacy of post-exposure prophylaxis against Marburg virus infection. AVI-7288 is one of two components that make up AVI-6003. Studies conducted to date have shown that efficacy in non-human primates can be attributed to this single component, while the second component, AVI-7287, does not appear to contribute to efficacy. AVI is conducting this work under a Department of Defense contract managed by the Joint Project Manager Transformational Medical Technologies (JPM-TMT) Project Management Office, a component of the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD). The FDA approved proceeding with the Marburg program using the single oligomer AVI-7288 under the original IND.

http://finance.yahoo.com/news/AVI-BioPharma-Announces-FDA-iw-4179795439.html?x=0

Investor 100